MARKET

PRVB

PRVB

PROVENTION BIO, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.20
+0.38
+2.56%
Closed 18:01 09/18 EDT
OPEN
15.04
PREV CLOSE
14.82
HIGH
15.44
LOW
14.83
VOLUME
1.75M
TURNOVER
--
52 WEEK HIGH
18.50
52 WEEK LOW
4.720
MARKET CAP
855.46M
P/E (TTM)
-12.9307
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average PRVB stock price target is 28.00 with a high estimate of 35.00 and a low estimate of 25.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About PRVB
Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Provention Bio Inc stock information, including NASDAQ:PRVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRVB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRVB stock methods without spending real money on the virtual paper trading platform.